Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE044A01036 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Sun Pharmaceut Sun Pharmaceutical Industries Ltd. | BSE 1730.80 10.40 (0.60%) | NSE 1730.70 9.60 (0.56%) | Trade | Add

BSE Live

Jan 02, 10:51

1730.80 10.40 (0.60%)

Volume

AVERAGE VOLUME

5-Day

65,565

10-Day

103,671

30-Day

84,174

3,010

Prev. Close

1720.40
Open Price

1722.00

Bid Price (Qty.)
1730.30 (40)
Offer Price (Qty.)
1730.80 (24)

NSE Live

Jan 02, 10:51

1730.70 9.60 (0.56%)

Volume

AVERAGE VOLUME

5-Day

1,850,721

10-Day

2,030,084

30-Day

2,003,431

143,814

Prev. Close

1721.10
Open Price

1721.10

Bid Price (Qty.)
1730.50 (498)
Offer Price (Qty.)
1730.70 (124)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Sun Pharmaceutical Industries (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	1,891.16	2,833.65	2,427.35	1,722.13	1,353.01
Less: Excise/Sevice Tax/Other Levies	46.07	59.00	58.84	59.57	61.37
Revenue From Operations [Net]	1,845.09	2,774.65	2,368.51	1,662.56	1,291.64
Total Operating Revenues	1,845.09	2,774.65	2,368.51	1,662.56	1,291.64
Other Income	765.98	1,276.22	914.83	750.26	525.55
Total Revenue	2,611.07	4,050.87	3,283.34	2,412.82	1,817.19
EXPENSES
Cost Of Materials Consumed	788.80	741.66	644.15	537.18	442.11
Purchase Of Stock-In Trade	137.04	1,270.67	957.82	708.44	483.11
Operating And Direct Expenses	52.90	43.93	35.21	25.08	23.11
Changes In Inventories Of FG,WIP And Stock-In Trade	-30.91	-23.78	-17.38	-41.41	-57.23
Employee Benefit Expenses	174.71	148.31	120.20	98.87	82.01
Finance Costs	0.44	2.77	5.06	8.80	11.23
Depreciation And Amortisation Expenses	69.47	58.86	56.11	46.27	40.73
Other Expenses	471.03	513.04	429.97	389.05	303.44
Total Expenses	1,663.48	2,755.46	2,231.14	1,772.28	1,328.51
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	947.59	1,295.41	1,052.20	640.54	488.68
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	947.59	1,295.41	1,052.20	640.54	488.68
Tax Expenses-Continued Operations
Current Tax	52.60	24.10	33.09	5.63	7.38
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-2.09	4.48	3.62	4.88	19.14
Tax For Earlier Years	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	50.51	30.12	38.16	11.61	27.39
Profit/Loss After Tax And Before ExtraOrdinary Items	897.08	1,265.29	1,014.04	628.93	461.29
Profit/Loss From Continuing Operations	898.65	1,276.99	1,014.04	628.88	461.29
Profit/Loss For The Period	898.65	1,276.99	1,014.04	628.88	461.29
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	43.39	61.65	48.96	32.52	24.84
Diluted EPS (Rs.)	43.39	61.65	48.96	32.52	24.84
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	314.73	276.01	234.89	192.77	174.00
Indigenous Raw Materials	394.43	386.98	351.41	298.18	231.01
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.33	0.25	0.23	0.09	0.14
Indigenous Stores And Spares	31.93	27.98	20.26	15.00	11.41
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	284.79	284.79	217.47	130.01	102.30
Tax On Dividend	47.30	48.40	37.20	18.25	14.36
Equity Dividend Rate (%)	275.00	275.00	210.00	135.00	110.00